{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:51:48Z","timestamp":1789663908198,"version":"4.0.1"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.gtc.2011.03.008","type":"journal-article","created":{"date-parts":[[2011,4,18]],"date-time":"2011-04-18T16:42:59Z","timestamp":1303144979000},"page":"373-386","source":"Crossref","is-referenced-by-count":21,"title":["Primary Biliary Cirrhosis"],"prefix":"10.1016","volume":"40","author":[{"given":"Bhavik M.","family":"Bhandari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Bayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth D.","family":"Rothstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gtc.2011.03.008_bib1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(65)91372-3","article-title":"Serological tests in diagnosis of primary biliary cirrhosis","volume":"285","author":"Walker","year":"1965","journal-title":"Lancet"},{"issue":"987","key":"10.1016\/j.gtc.2011.03.008_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/gut.2007.122150","article-title":"Pathogenesis of primary biliary cirrhosis","volume":"84","author":"Jones","year":"2008","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.gtc.2011.03.008_bib3","series-title":"Sleisenger & Fordtran\u2019s gastrointestinal and liver disease pathophysiology, diagnosis, management","article-title":"Primary biliary cirrhosis","author":"Angulo","year":"2009"},{"key":"10.1016\/j.gtc.2011.03.008_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.03.008_bib5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jhep.2009.11.027","article-title":"Primary biliary cirrhosis: a 2010 update","volume":"52","author":"Poupon","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.gtc.2011.03.008_bib6","first-page":"265","article-title":"On a certain affection of the skin vitiligoidea-\u03b1 plana, \u03b2 tuberosa","volume":"7","author":"Addison","year":"1851","journal-title":"Guys Hosp Rep"},{"key":"10.1016\/j.gtc.2011.03.008_bib7","first-page":"1","article-title":"Primary biliary cirrhosis","volume":"61","author":"Dauphinee","year":"1949","journal-title":"CMAJ"},{"key":"10.1016\/j.gtc.2011.03.008_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00005792-195012000-00002","article-title":"Primary biliary cirrhosis","volume":"29","author":"Ahrens","year":"1950","journal-title":"Medicine"},{"key":"10.1016\/j.gtc.2011.03.008_bib9","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0016-5085(19)35377-6","article-title":"Primary biliary cirrhosis (chronic intrahepatic obstructive jaundice)","volume":"37","author":"Sherlock","year":"1959","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.03.008_bib10","first-page":"609","article-title":"Mitochondrial and other tissue antibodies in relatives of patients with primary biliary cirrhosis","volume":"10","author":"Feizi","year":"1972","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.gtc.2011.03.008_bib11","first-page":"387","article-title":"Primary biliary cirrhosis: chronic non-suppurative destructive cholangitis","volume":"46","author":"Rubin","year":"1965","journal-title":"Am J Pathol"},{"key":"10.1016\/j.gtc.2011.03.008_bib12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/bmj.2.6187.419","article-title":"Are increased individual susceptibility and environmental factors both necessary for the development of primary biliary cirrhosis?","volume":"2","author":"Douglas","year":"1979","journal-title":"BMJ"},{"key":"10.1016\/j.gtc.2011.03.008_bib13","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/bmj.281.6243.772","article-title":"Primary biliary cirrhosis: an epidemiological study","volume":"281","author":"Triger","year":"1980","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.gtc.2011.03.008_bib14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1089-3261(03)00098-9","article-title":"Primary biliary cirrhosis: historical perspective","volume":"7","author":"Heathcote","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.gtc.2011.03.008_bib15","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/gast.2000.20197","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a US community","volume":"119","author":"Kim","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.03.008_bib16","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1089-3261(03)00102-8","article-title":"The epidemiology of primary biliary cirrhosis","volume":"7","author":"Prince","year":"2003","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.gtc.2011.03.008_bib17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cld.2008.02.001","article-title":"Recent advances in the epidemiology of primary biliary cirrhosis","volume":"12","author":"Gross","year":"2008","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.gtc.2011.03.008_bib18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","article-title":"Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gtc.2011.03.008_bib19","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1089-3261(03)00095-3","article-title":"Genetic factors in the pathogenesis of primary biliary cirrhosis","volume":"7","author":"Jones","year":"2003","journal-title":"Clin Liver Dis"},{"issue":"6","key":"10.1016\/j.gtc.2011.03.008_bib20","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/hep.21423","article-title":"Smoking and increased severity of hepatic fibrosis in primary biliary cirrhosis: a cross validated retrospective assessment","volume":"44","author":"Zein","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.gtc.2011.03.008_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/jhep.2001.21165","article-title":"Risk factors for primary biliary cirrhosis in a cohort of patients from the United States","volume":"33","author":"Parikh-Patel","year":"2001","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.gtc.2011.03.008_bib22","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jhep.2003.11.033","article-title":"Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae?","volume":"40","author":"Abdulkarim","year":"2004","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.gtc.2011.03.008_bib23","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1053\/jhep.2003.50446","article-title":"Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium","volume":"38","author":"Selmi","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.03.008_bib24","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.4049\/jimmunol.170.10.5326","article-title":"Immunization with a xenobiotic 6-bromohexane bovine serum albumin conjugate induces antimitochondrial antibodies","volume":"170","author":"Leung","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.gtc.2011.03.008_bib25","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"issue":"9408","key":"10.1016\/j.gtc.2011.03.008_bib26","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)15541-4","article-title":"Frequency of monosomy X in women with primary biliary cirrhosis","volume":"363","author":"Invernizzi","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.gtc.2011.03.008_bib27","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1047-2797(01)00277-0","article-title":"The association between gravidity and primary biliary cirrhosis","volume":"12","author":"Parikh-Patel","year":"2002","journal-title":"Ann Epidemiol"},{"issue":"4","key":"10.1016\/j.gtc.2011.03.008_bib28","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S1089-3261(03)00101-6","article-title":"Primary biliary cirrhosis\u2013presentation and diagnosis","volume":"7","author":"Leuschner","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.gtc.2011.03.008_bib29","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/gut.27.11.1373","article-title":"Primary biliary cirrhosis in man","volume":"27","author":"Lucey","year":"1986","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.gtc.2011.03.008_bib30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1034\/j.1600-0528.2002.00021h.x","article-title":"Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis","volume":"174","author":"Yeaman","year":"2000","journal-title":"Immunol Rev"},{"issue":"9","key":"10.1016\/j.gtc.2011.03.008_bib31","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI0214698","article-title":"Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis","volume":"109","author":"Kita","year":"2002","journal-title":"J\u00a0Clin Invest"},{"issue":"8785","key":"10.1016\/j.gtc.2011.03.008_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0140-6736(92)91001-O","article-title":"Membrane dihydrolipoamide acetyltransferase (E2) on human biliary epithelial cells in primary biliary cirrhosis","volume":"339","author":"Joplin","year":"1992","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.gtc.2011.03.008_bib33","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3748\/wjg.14.3328","article-title":"Etiopathogenesis of primary biliary cirrhosis","volume":"14","author":"Invernizzi","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.gtc.2011.03.008_bib34","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0168-8278(05)80139-4","article-title":"Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years","volume":"20","author":"Mahl","year":"1994","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.gtc.2011.03.008_bib35","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cld.2008.02.014","article-title":"Presentation and diagnosis of primary biliary cirrhosis in the 21st century","volume":"12","author":"Kumagi","year":"2008","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.gtc.2011.03.008_bib36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cld.2008.02.010","article-title":"Fatigue in primary biliary cirrhosis","volume":"12","author":"Newton","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.gtc.2011.03.008_bib37","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1572-0241.2000.01857.x","article-title":"Impact of fatigue on the quality of life in patients with primary biliary cirrhosis","volume":"95","author":"Huet","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.gtc.2011.03.008_bib38","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1136\/gut.2005.065862","article-title":"Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis","volume":"54","author":"Jacoby","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2011.03.008_bib39","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/gut.43.5.705","article-title":"Fatigue in primary biliary cirrhosis","volume":"43","author":"Cauch-Dudek","year":"1998","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.gtc.2011.03.008_bib40","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cld.2008.02.013","article-title":"Pruritus in primary biliary cirrhosis: pathogenesis and therapy","volume":"12","author":"Bergasa","year":"2008","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.gtc.2011.03.008_bib41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cld.2008.02.005","article-title":"Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment","volume":"12","author":"Pares","year":"2008","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.gtc.2011.03.008_bib42","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jhep.2004.11.035","article-title":"Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis","volume":"42","author":"Guanabens","year":"2005","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.gtc.2011.03.008_bib43","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1053\/j.gastro.2006.09.012","article-title":"Fracture risk in people with primary biliary cirrhosis: a population-based cohort study","volume":"131","author":"Solaymanidodaran","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.03.008_bib44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-137-6-200209170-00015","article-title":"Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force","volume":"137","author":"Nelson","year":"2002","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.gtc.2011.03.008_bib45","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jhep.2006.06.007","article-title":"Treatment of bone disorders in liver disease","volume":"45","author":"Pares","year":"2006","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.gtc.2011.03.008_bib46","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S1089-3261(03)00097-7","article-title":"Management of osteoporosis, fat-soluble vitamin deficiencies, and hyperlipidemia in primary biliary cirrhosis","volume":"7","author":"Levy","year":"2003","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.gtc.2011.03.008_bib47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/00365529709025067","article-title":"Primary biliary cirrhosis in the Netherlands: an analysis of associated diseases, cardiovascular risk, and malignancies on the basis of mortality figures","volume":"32","author":"Van Dam","year":"1997","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.gtc.2011.03.008_bib48","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.atherosclerosis.2006.11.036","article-title":"Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: a systematic review","volume":"194","author":"Sorokin","year":"2007","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.gtc.2011.03.008_bib49","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.cld.2008.02.003","article-title":"Antimitochondrial antibody-negative primary biliary cirrhosis","volume":"12","author":"Hirschfield","year":"2008","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.gtc.2011.03.008_bib50","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","article-title":"Frequency and nature of the variant syndromes of autoimmune liver disease","volume":"28","author":"Czaja","year":"1998","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.gtc.2011.03.008_bib51","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/hep.1840190610","article-title":"Distribution of pyruvate dehydrogenase dihydrolipoamide acetyltransferase (PDC-E2) and another mitochondrial marker in salivary gland and biliary epithelium from patients with primary biliary cirrhosis","volume":"19","author":"Joplin","year":"1994","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.gtc.2011.03.008_bib52","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0002-9343(84)90861-1","article-title":"Malignancy in primary biliary cirrhosis. High incidence of breast cancer in affected women","volume":"76","author":"Wolke","year":"1984","journal-title":"Am J Med"},{"issue":"6509","key":"10.1016\/j.gtc.2011.03.008_bib53","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1136\/bmj.291.6509.1597","article-title":"Breast cancer in women with primary biliary cirrhosis","volume":"291","author":"Goudie","year":"1985","journal-title":"Br Med J"},{"issue":"5","key":"10.1016\/j.gtc.2011.03.008_bib54","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/hep.510290501","article-title":"Hepatic and extrahepatic malignancies in primary biliary cirrhosis","volume":"29","author":"Floreani","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.03.008_bib55","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cld.2008.02.012","article-title":"Natural history of primary biliary cirrhosis","volume":"12","author":"Mayo","year":"2008","journal-title":"Clin Liver Dis"},{"issue":"9039","key":"10.1016\/j.gtc.2011.03.008_bib56","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.gtc.2011.03.008_bib57","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/hep.510290511","article-title":"Incidence of cancer in primary biliary cirrhosis: the Mayo experience","volume":"29","author":"Nijhawan","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.03.008_bib58","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1089-3261(03)00092-8","article-title":"Autoimmune overlapping syndromes","volume":"7","author":"Poupon","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.gtc.2011.03.008_bib59","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/gut.49.2.276","article-title":"Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant","volume":"49","author":"Vleggaar","year":"2001","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.gtc.2011.03.008_bib60","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","article-title":"Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited","volume":"36","author":"Paumgartner","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.03.008_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000551.pub2","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","volume":"3","author":"Gong","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"15","key":"10.1016\/j.gtc.2011.03.008_bib62","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMct074694","article-title":"Ursodeoxycholic acid for the treatment of primary biliary cirrhosis","volume":"357","author":"Lindor","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gtc.2011.03.008_bib63","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1572-0241.2006.00634.x","article-title":"Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials","volume":"101","author":"Shi","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2011.03.008_bib64","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0168-8278(99)80136-6","article-title":"Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial","volume":"30","author":"Angulo","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.gtc.2011.03.008_bib65","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00004836-200308000-00018","article-title":"Treatment with ursodeoxycholic acid is associated with weight gain in patients with primary biliary cirrhosis","volume":"37","author":"Siegel","year":"2003","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.gtc.2011.03.008_bib66","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/gut.46.1.121","article-title":"Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment","volume":"46","author":"Leuschner","year":"2000","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.gtc.2011.03.008_bib67","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1111\/j.1572-0241.2001.05270.x","article-title":"Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile?","volume":"96","author":"Angulo","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2011.03.008_bib68","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/gast.1999.0029900395","article-title":"Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol","volume":"117","author":"Bonis","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.03.008_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004385.pub3","article-title":"Methotrexate for primary biliary cirrhosis","volume":"5","author":"Giljaca","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gtc.2011.03.008_bib70","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0016-5085(99)70403-8","article-title":"A\u00a0prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis","volume":"117","author":"Kaplan","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.03.008_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004789.pub2","article-title":"Colchicine for primary biliary cirrhosis","volume":"2","author":"Gong","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.gtc.2011.03.008_bib72","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cld.2008.02.008","article-title":"Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents","volume":"12","author":"Silveira","year":"2008","journal-title":"Clin Liver Dis"},{"issue":"10","key":"10.1016\/j.gtc.2011.03.008_bib73","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1007\/s10620-008-0613-3","article-title":"Modafinil in the treatment of debilitating fatigue in primary biliary cirrhosis: a clinical experience","volume":"54","author":"Ian Gan","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2011.03.008_bib74","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0016-5085(88)90442-8","article-title":"Treatment of pruritus in primary biliary cirrhosis with rifampin: results of a double-blind, crossover, randomized trial","volume":"94","author":"Ghent","year":"1988","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gtc.2011.03.008_bib75","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/0016-5085(95)90696-7","article-title":"A\u00a0placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid","volume":"108","author":"Vuoristo","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.03.008_bib76","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/hep.1840110526","article-title":"The pruritus of cholestasis: from bile acids to opiate agonists","volume":"11","author":"Jones","year":"1990","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.gtc.2011.03.008_bib77","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMoa055218","article-title":"Calcium plus vitamin D supplementation and the risk of fractures","volume":"354","author":"Jackson","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gtc.2011.03.008_bib78","first-page":"S279","article-title":"Alendronate 70 mg once-weekly is more effective and has a better tolerability than alendronate 10 mg daily in the treatment of osteopenia associated with primary biliary cirrhosis","volume":"20","author":"Guanabens","year":"2005","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.gtc.2011.03.008_bib79","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0025-6196(12)61815-1","article-title":"Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis","volume":"69","author":"Balan","year":"1994","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.gtc.2011.03.008_bib80","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0168-8278(02)00006-5","article-title":"Simvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers","volume":"36","author":"Ritzel","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.gtc.2011.03.008_bib81","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1572-0241.2002.05413.x","article-title":"Investigation into the efficacy of bezafibrate against primary biliary cirrhosis, with histological references from cases receiving long term monotherapy","volume":"97","author":"Kurihara","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2011.03.008_bib82","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cld.2008.02.015","article-title":"Liver transplantation in primary biliary cirrhosis","volume":"12","author":"Milkiewicz","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.gtc.2011.03.008_bib83","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0168-8278(03)00283-6","article-title":"Liver transplantation for primary biliary cirrhosis: indications and risk of recurrence","volume":"39","author":"Neuberger","year":"2003","journal-title":"J\u00a0Hepatol"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855311000264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855311000264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T03:55:26Z","timestamp":1560138926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855311000264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0889855311000264"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2011.03.008","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}